Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Engene Inc.

4868 Levy Street Suite 220, H4R 2P1

About the sponsor

Engene Inc. is focused on non-muscle invasive bladder cancer, with research centered on high-risk bladder tumors and disease that remains active after prior BCG treatment.

  • Non-muscle invasive bladder cancer
  • BCG-unresponsive disease
  • High-risk NMIBC

The sponsor’s clinical activity in this area reflects a specific therapeutic interest in bladder-preserving treatment options for patients with limited local disease control.

About Specializations

Engene Inc. runs clinical trials in conditions such as Bladder cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Bladder cancer

Recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Lauromacrogol 400
  • Sponsor:Engene Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.